CN118742316A - 用于抑制癌转移的vipr2拮抗肽 - Google Patents

用于抑制癌转移的vipr2拮抗肽 Download PDF

Info

Publication number
CN118742316A
CN118742316A CN202280092332.XA CN202280092332A CN118742316A CN 118742316 A CN118742316 A CN 118742316A CN 202280092332 A CN202280092332 A CN 202280092332A CN 118742316 A CN118742316 A CN 118742316A
Authority
CN
China
Prior art keywords
acid
peptide
cells
group
vipr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280092332.XA
Other languages
English (en)
Chinese (zh)
Inventor
吾乡由希夫
浅野智志
坂元孝太郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hiroshima University
Ichimaru Pharcos Co Ltd
Original Assignee
Hiroshima University
Ichimaru Pharcos Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hiroshima University, Ichimaru Pharcos Co Ltd filed Critical Hiroshima University
Publication of CN118742316A publication Critical patent/CN118742316A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN202280092332.XA 2022-02-25 2022-12-26 用于抑制癌转移的vipr2拮抗肽 Pending CN118742316A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-027791 2022-02-25
JP2022027791 2022-02-25
PCT/JP2022/047969 WO2023162456A1 (ja) 2022-02-25 2022-12-26 癌転移抑制用のvipr2アンタゴニストペプチド

Publications (1)

Publication Number Publication Date
CN118742316A true CN118742316A (zh) 2024-10-01

Family

ID=87765588

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280092332.XA Pending CN118742316A (zh) 2022-02-25 2022-12-26 用于抑制癌转移的vipr2拮抗肽

Country Status (5)

Country Link
US (1) US20250186540A1 (cg-RX-API-DMAC7.html)
EP (1) EP4473973A4 (cg-RX-API-DMAC7.html)
JP (1) JP7339471B1 (cg-RX-API-DMAC7.html)
CN (1) CN118742316A (cg-RX-API-DMAC7.html)
WO (1) WO2023162456A1 (cg-RX-API-DMAC7.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021200259A1 (ja) * 2020-03-30 2021-10-07 一丸ファルコス株式会社 Vipr2アンタゴニストペプチド

Also Published As

Publication number Publication date
EP4473973A1 (en) 2024-12-11
WO2023162456A1 (ja) 2023-08-31
JPWO2023162456A1 (cg-RX-API-DMAC7.html) 2023-08-31
JP7339471B1 (ja) 2023-09-05
US20250186540A1 (en) 2025-06-12
EP4473973A4 (en) 2026-01-21

Similar Documents

Publication Publication Date Title
US9937240B2 (en) Peptide having fibrosis inhibitory activity and composition containing same
JP5355561B2 (ja) 生物活性ペプチドおよびその使用方法
WO2015056713A1 (ja) c-Metタンパク質アゴニスト
KR20010023449A (ko) 신규한 환상 테트라펩티드 유도체 및 그 의약 용도
KR20090090315A (ko) 메타스틴 유도체 및 그의 용도
KR101368607B1 (ko) 메타스틴 유도체 및 그의 용도
JP4335910B2 (ja) メタスチン誘導体およびその使用
JP2025036429A (ja) プロテアーゼ活性化受容体2のモジュレーター
JP2009523157A (ja) 虚血および神経変性の処置のための化合物
EP3970801A1 (en) Ras inhibitory peptide
ES2400567T3 (es) Inhibidores de cinasa de la cadena ligera de miosina y su uso
JP6735676B2 (ja) C−fosの選択的インヒビターおよびその抗増殖特性
WO2017217545A1 (ja) プレキシンの結合調節剤
JP7339471B1 (ja) 癌転移抑制用のvipr2アンタゴニストペプチド
JP7417010B1 (ja) 癌免疫増強用のvipr2アンタゴニストペプチド
WO2021200259A1 (ja) Vipr2アンタゴニストペプチド
JP7181550B2 (ja) ペプチド、その薬学的に許容される塩、またはそれらのプロドラッグ、およびそれらの用途
JP7464310B2 (ja) Wntシグナル伝達経路の抑制剤
JP2011512364A (ja) 治療用ペプチド
WO2014119753A4 (ja) マイオスタチン阻害ペプチド
JP2019522041A (ja) 新規のペプチド及びペプチド模倣体
US20210395310A1 (en) Cyclic Peptide
WO2005115394A2 (en) Prenyl-electrostatic switch, and methods of use
US11541101B1 (en) LEMD3 antagonizes TGF-beta-driven Smad2/3 transcription in a stiffness-dependent fashion in both the nucleus and cytosol
WO2019117691A1 (ko) CD44v6에 결합하는 펩타이드 및 이의 용도

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination